Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Receivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Arcus Biosciences (RCUS) Total Current Liabilities (2017 - 2025)

Historic Total Current Liabilities for Arcus Biosciences (RCUS) over the last 9 years, with Q3 2025 value amounting to $235.0 million.

  • Arcus Biosciences' Total Current Liabilities rose 930.23% to $235.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $235.0 million, marking a year-over-year increase of 930.23%. This contributed to the annual value of $226.0 million for FY2024, which is 2282.61% up from last year.
  • Latest data reveals that Arcus Biosciences reported Total Current Liabilities of $235.0 million as of Q3 2025, which was up 930.23% from $210.0 million recorded in Q2 2025.
  • In the past 5 years, Arcus Biosciences' Total Current Liabilities registered a high of $235.0 million during Q3 2025, and its lowest value of $130.4 million during Q2 2021.
  • In the last 5 years, Arcus Biosciences' Total Current Liabilities had a median value of $184.0 million in 2023 and averaged $183.7 million.
  • Data for Arcus Biosciences' Total Current Liabilities shows a peak YoY increase of 52871.36% (in 2021) and a maximum YoY decrease of 1228.27% (in 2021) over the last 5 years.
  • Quarter analysis of 5 years shows Arcus Biosciences' Total Current Liabilities stood at $166.0 million in 2021, then rose by 16.27% to $193.0 million in 2022, then dropped by 4.66% to $184.0 million in 2023, then increased by 22.83% to $226.0 million in 2024, then grew by 3.98% to $235.0 million in 2025.
  • Its Total Current Liabilities was $235.0 million in Q3 2025, compared to $210.0 million in Q2 2025 and $192.0 million in Q1 2025.